Edition:
United Kingdom

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

0.97USD
23 Feb 2018
Change (% chg)

$-0.00 (-0.27%)
Prev Close
$0.97
Open
$0.97
Day's High
$1.00
Day's Low
$0.95
Volume
5,882
Avg. Vol
80,779
52-wk High
$2.05
52-wk Low
$0.91

Chart for

About

OvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's... (more)

Overall

Beta: 3.53
Market Cap(Mil.): $49.96
Shares Outstanding(Mil.): 35.69
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-OvaScience Says Provided Intrexon Corp With Written Notice Of Termination Of Exclusive Channel Collaboration Agreement, Dated Dec 18, 2013

* OVASCIENCE SAYS PROVIDED INTREXON CORP WITH WRITTEN NOTICE OF TERMINATION OF EXCLUSIVE CHANNEL COLLABORATION AGREEMENT, DATED DEC 18, 2013-SEC FILING

01 Feb 2018

BRIEF-Ovascience Says ‍Reducing Headcount By Approximately 50 Percent​

* OVASCIENCE INC - ‍REDUCING HEADCOUNT BY APPROXIMATELY 50 PERCENT​

03 Jan 2018

BRIEF-Ovascience reports Q3 loss per share $0.26

* Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S

02 Nov 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $132.02 +2.11
Pfizer Inc. (PFE.N) $36.26 +0.52
Merck & Co., Inc. (MRK.N) $54.87 +0.30
Sanofi SA (SASY.PA) €65.05 +0.16
Eli Lilly and Co (LLY.N) $78.75 +1.56
Abbott Laboratories (ABT.N) $59.71 +0.72

Earnings vs. Estimates